Owens & Minor (NYSE:OMI) Issues FY24 Earnings Guidance

Owens & Minor (NYSE:OMI) issued an update on its FY24 earnings guidance on Monday morning. The company provided EPS guidance of $1.45-1.55 for the period, compared to the consensus EPS estimate of $1.60. The company issued revenue guidance of $10.6-10.8 billion, compared to the consensus revenue estimate of $10.71 billion. Owens & Minor also updated its FY 2024 guidance to 1.450-1.550 EPS.

Owens & Minor Price Performance

NYSE OMI traded up $1.16 on Wednesday, reaching $12.96. The company’s stock had a trading volume of 182,781 shares, compared to its average volume of 831,926. Owens & Minor has a 52 week low of $11.42 and a 52 week high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17. The business has a 50-day moving average price of $14.46 and a 200 day moving average price of $16.10. The firm has a market cap of $999.22 million, a PE ratio of -21.04, a price-to-earnings-growth ratio of 0.43 and a beta of 0.41.

Owens & Minor (NYSE:OMI) last issued its earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.44 EPS. Sell-side analysts expect that Owens & Minor will post 1.57 EPS for the current year.

Analyst Ratings Changes

OMI has been the topic of several research analyst reports. Citigroup decreased their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday. Barclays lowered their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday. UBS Group reduced their price target on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. dropped their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 21st. Finally, StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, Owens & Minor has an average rating of “Hold” and a consensus target price of $18.50.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.